Clinical Trial Update: SMS 2: Impact of Cancer Therapy on the Somatic Mutational Landscape of Normal Tissues

View source ↗

Summary

An ongoing clinical trial update describing SMS 2, a study on how cancer therapies influence the somatic mutational landscape of normal tissues.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: The Wellcome Sanger Institute | Conditions: Somatic Mutation, Cancer | Status: ENROLLING_BY_INVITATION